Posttransplant Lymphoproliferative Disorder

  • Michael T. Corwin


Posttransplant lymphoproliferative disorder (PTLD) is a common malignancy arising after solid organ transplantation. Clinical features are nonspecific and imaging plays an important role in the diagnosis. The location of disease is dependent on the type of organ transplantation although, generally, the transplanted organ itself is commonly affected. Extra-nodal disease is more common than nodal disease, and aside from the transplanted organ, the bowel and central nervous system (CNS) are frequently affected organs. Solitary or multifocal hypo-enhancing masses are often seen with solid organ involvement, though an infiltrating mass is also encountered. Bowel wall thickening with aneurysmal dilation is a classic finding in small bowel PTLD. Multiple pulmonary nodules are the most common appearance of thoracic PTLD, and single or multiple enhancing brain masses are seen with CNS involvement. This chapter will discuss the imaging appearances of PTLD throughout the body.


Posttransplant lymphoproliferative disorder PTLD Lymphoma Solid organ transplantation CT Ultrasound PET/CT MRI 


  1. 1.
    Engels EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK, Snyder JJ, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA. 2011;306(17):1891–901.CrossRefPubMedCentralPubMedGoogle Scholar
  2. 2.
    Collett D, Mumford L, Banner NR, Neuberger J, Watson C. Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit. Am J Transplant. 2010;10(8):1889–96.CrossRefPubMedGoogle Scholar
  3. 3.
    Adami J, Gabel H, Lindelof B, Ekstrom K, Rydh B, Glimelius B, et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer. 2003;89(7):1221–7.CrossRefPubMedCentralPubMedGoogle Scholar
  4. 4.
    Taylor AL, Marcus R, Bradley JA. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit Rev Oncol Hematol. 2005;56(1):155–67.CrossRefPubMedGoogle Scholar
  5. 5.
    Borhani AA, Hosseinzadeh K, Almusa O, Furlan A, Nalesnik M. Imaging of posttransplantation lymphoproliferative disorder after solid organ transplantation. Radiographics. 2009;29(4):981–1000; discussion-2.CrossRefPubMedGoogle Scholar
  6. 6.
    Gao SZ, Chaparro SV, Perlroth M, Montoya JG, Miller JL, DiMiceli S, et al. Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University. J Heart Lung Transplant. 2003;22(5):505–14.CrossRefPubMedGoogle Scholar
  7. 7.
    Libertiny G, Watson CJ, Gray DW, Welsh KI, Morris PJ. Rising incidence of post-transplant lymphoproliferative disease in kidney transplant recipients. Br J Surg. 2001;88(10):1330–4.CrossRefPubMedGoogle Scholar
  8. 8.
    Paranjothi S, Yusen RD, Kraus MD, Lynch JP, Patterson GA, Trulock EP. Lymphoproliferative disease after lung transplantation: comparison of presentation and outcome of early and late cases. J Heart Lung Transplant. 2001;20(10):1054–63.CrossRefPubMedGoogle Scholar
  9. 9.
    Dhillon MS, Rai JK, Gunson BK, Olliff S, Olliff J. Post-transplant lymphoproliferative disease in liver transplantation. Br J Radiol. 2007;80(953):337–46.CrossRefPubMedGoogle Scholar
  10. 10.
    Opelz G, Dohler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant. 2004;4(2):222–30.CrossRefPubMedGoogle Scholar
  11. 11.
    Fananapazir G, Troppmann C, Corwin MT, Nikpour AM, Naderi S, Lamba R. Incidences of acute kidney injury, dialysis, and graft loss following intravenous administration of low-osmolality iodinated contrast in patients with kidney transplants. Abdom Radiol. 2016;41(11):2182–6.CrossRefGoogle Scholar
  12. 12.
    Bianchi E, Pascual M, Nicod M, Delaloye AB, Duchosal MA. Clinical usefulness of FDG-PET/CT scan imaging in the management of posttransplant lymphoproliferative disease. Transplantation. 2008;85(5):707–12.CrossRefPubMedGoogle Scholar
  13. 13.
    McCormack L, Hany TI, Hubner M, Petrowsky H, Mullhaupt B, Knuth A, et al. How useful is PET/CT imaging in the management of post-transplant lymphoproliferative disease after liver transplantation? Am J Transplant. 2006;6(7):1731–6.CrossRefPubMedGoogle Scholar
  14. 14.
    Vali R, Punnett A, Bajno L, Moineddin R, Shammas A. The value of 18F-FDG PET in pediatric patients with post-transplant lymphoproliferative disorder at initial diagnosis. Pediatr Transplant. 2015;19(8):932–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Miller WT Jr, Siegel SG, Montone KT. Posttransplantation lymphoproliferative disorder: changing manifestations of disease in a renal transplant population. Crit Rev Diagn Imaging. 1997;38(6):569–85.PubMedGoogle Scholar
  16. 16.
    Pickhardt PJ, Siegel MJ. Posttransplantation lymphoproliferative disorder of the abdomen: CT evaluation in 51 patients. Radiology. 1999;213(1):73–8.CrossRefPubMedGoogle Scholar
  17. 17.
    Ghai S, Pattison J, Ghai S, O’Malley ME, Khalili K, Stephens M. Primary gastrointestinal lymphoma: spectrum of imaging findings with pathologic correlation. Radiographics. 2007;27(5):1371–88.CrossRefPubMedGoogle Scholar
  18. 18.
    Shin YM. Posttransplantation lymphoproliferative disorder involving liver after renal transplantation. Korean J Hepatol. 2011;17(2):165–9.CrossRefPubMedCentralPubMedGoogle Scholar
  19. 19.
    Wu L, Rappaport DC, Hanbidge A, Merchant N, Shepherd FA, Greig PD. Lymphoproliferative disorders after liver transplantation: imaging features. Abdom Imaging. 2001;26(2):200–6.CrossRefPubMedGoogle Scholar
  20. 20.
    Semelka RC, Kelekis NL, Sallah S, Worawattanakul S, Ascher SM. Hepatosplenic fungal disease: diagnostic accuracy and spectrum of appearances on MR imaging. AJR Am J Roentgenol. 1997;169(5):1311–6.CrossRefPubMedGoogle Scholar
  21. 21.
    Lopez-Ben R, Smith JK, Kew CE 2nd, Kenney PJ, Julian BA, Robbin ML. Focal posttransplantation lymphoproliferative disorder at the renal allograft hilum. AJR Am J Roentgenol. 2000;175(5):1417–22.CrossRefPubMedGoogle Scholar
  22. 22.
    Ali MG, Coakley FV, Hricak H, Bretan PN. Complex posttransplantation abnormalities of renal allografts: evaluation with MR imaging. Radiology. 1999;211(1):95–100.CrossRefPubMedGoogle Scholar
  23. 23.
    Meador TL, Krebs TL, Cheong JJWY, Daly B, Keay S, Bartlett S. Imaging features of posttransplantation lymphoproliferative disorder in pancreas transplant recipients. Am J Roentgenol. 2000;174(1):121–4.CrossRefGoogle Scholar
  24. 24.
    Dyckmans K, Lerut E, Gillard P, Lannoo M, Ectors N, Hoorens A, et al. Post-transplant lymphoma of the pancreatic allograft in a kidney-pancreas transplant recipient: a misleading presentation. Nephrol Dial Transplant. 2006;21(11):3306–10.CrossRefPubMedGoogle Scholar
  25. 25.
    Hare SS, Souza CA, Bain G, Seely JM, Frcpc, Gomes MM, et al. The radiological spectrum of pulmonary lymphoproliferative disease. Br J Radiol. 2012;85(1015):848–64.CrossRefPubMedCentralPubMedGoogle Scholar
  26. 26.
    Collins J, Muller NL, Leung AN, McGuinness G, Mergo PJ, Flint JD, et al. Epstein-Barr-virus-associated lymphoproliferative disease of the lung: CT and histologic findings. Radiology. 1998;208(3):749–59.CrossRefPubMedGoogle Scholar
  27. 27.
    Pickhardt PJ, Siegel MJ, Anderson DC, Hayashi R, DeBaun MR. Chest radiography as a predictor of outcome in posttransplantation lymphoproliferative disorder in lung allograft recipients. AJR Am J Roentgenol. 1998;171(2):375–82.CrossRefPubMedGoogle Scholar
  28. 28.
    Castellano-Sanchez AA, Li S, Qian J, Lagoo A, Weir E, Brat DJ. Primary central nervous system posttransplant lymphoproliferative disorders. Am J Clin Pathol. 2004;121(2):246–53.CrossRefPubMedGoogle Scholar
  29. 29.
    Pickhardt PJ, Wippold FJ 2nd. Neuroimaging in posttransplantation lymphoproliferative disorder. AJR Am J Roentgenol. 1999;172(4):1117–21.CrossRefPubMedGoogle Scholar
  30. 30.
    Cavaliere R, Petroni G, Lopes MB, Schiff D, International Primary Central Nervous System Lymphoma Collaborative Group. Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Cancer. 2010;116(4):863–70.CrossRefPubMedCentralPubMedGoogle Scholar
  31. 31.
    Loevner LA, Karpati RL, Kumar P, Yousem DM, Hsu W, Montone KT. Posttransplantation lymphoproliferative disorder of the head and neck: imaging features in seven adults. Radiology. 2000;216(2):363–9.CrossRefPubMedGoogle Scholar
  32. 32.
    Halkos ME, Miller JI, Mann KP, Miller DL, Gal AA. Thoracic presentations of posttransplant lymphoproliferative disorders. Chest. 2004;126(6):2013–20.CrossRefPubMedGoogle Scholar
  33. 33.
    Yoon GY, Kim MY, Huh JR, Jo KW, Shim TS. Posttransplant lymphoproliferative disorder of the thorax: CT and FDG-PET features in a single tertiary Referral Center. Medicine. 2015;94(31):e1274.CrossRefPubMedCentralPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.University of California, DavisSacramentoUSA

Personalised recommendations